| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |